APA (7th ed.) Citation

Khan, S., Marquez-Martinez, S., Erkens, T., Wilde, A. d., Costes, L. M. M., Vinken, P., . . . Wegmann, F. (2023). Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in Rabbits. MDPI AG.

Chicago Style (17th ed.) Citation

Khan, Selina, et al. Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in Rabbits. MDPI AG, 2023.

MLA (9th ed.) Citation

Khan, Selina, et al. Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in Rabbits. MDPI AG, 2023.